AstraZeneca's (AZN) Ultomiris Gets EU Nod for Rare Disease in KidsZacks Investment Research • 09/06/21
AstraZeneca's Ultomiris Scores European Nod For Rare Blood Disorder In Kids, AdolescentsBenzinga • 09/03/21
Covid Carries 'Much Higher' Blood Clot Risk Than Pfizer and AstraZeneca Vaccines: StudyBarrons • 08/27/21
AstraZeneca says ALXN1840 phase III trial in Wilson disease meets primary endpointProactive Investors • 08/26/21